Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Family Medicine

Clinical Trials: Rosacea


A listing of clinical trials currently looking for volunteers to enroll in Rosacea studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Radiant Research - Birmingham

Clinical Research for Rosacea

Birmingham : Radiant Research - Birmingham

Clinical Research for Rosacea

California

Santa Ana : Research Across America

Rosacea Research

Colorado

Denver : Horizons Clinical Research Center, LLC

Now enrolling for a clinical research study for the treatment of Rosacea.

Florida

Bradenton : Susan H. Weinkle, MD

A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea

Illinois

Chicago : Radiant Research - Chicago

Clinical Research Opportunity

View More »

Chicago : DeNova Research

A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea

Kentucky

Louisville : Dermatology Specialists Research, LLC

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Richmond : Melissa L.F. Knuckles MD, PSC

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Louisiana

New Orleans : Lupo Center for Aesthetic & General Dermatology

A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea

New York

New York : Diane Berson, MD

A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea

New York : Columbia University Medical Center

Open Label Pilot Study of Apremilast in Treatment of Rosacea

New York : Sadick Dermatology

Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea

New York : New York Laser & Skin Care

Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea

North Carolina

Hickory : PMG Research of Hickory

Are You Dealing With Red Pimply Skin? It Could Be Rosacea

Raleigh : Wake Research Associates

Study of Rosacea

Wilmington : PMG Research of Wilmington Updated

Do You Suffer From Facial Redness?

Winston Salem : PMG Research of Winston-Salem

Are You Dealing With Red Pimply Skin? It Could Be Rosacea

View More »

High Point : Zoe Draelos, MD Principal Investigator

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

South Carolina

Anderson : Radiant Research - Anderson

Cold Sores Research Opportunity

Anderson : Radiant Research - Anderson

What's News @ Radiant Research Anderson

Texas

Dallas : Research Across America

Rosacea Research Study

View More »

Austin : DermResearch, Inc

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Virginia

Lynchburg : The Education & Research Foundation, Inc.

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Canada

Victoria : Cosmedica

Ulthera System for the Treatment of Rosacea

Czech Republic

Chomutov : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Hradec Kralove : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Olomouc : Galderma Invetigational site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Pardubice : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Praha 1 : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

View More »

Slany : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

France

Bordeaux : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Brest : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Cannes : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Nice : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Saint Etienne : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Germany

Augsburg : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Bochum : Study site 5

Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)

Bonn : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Dresden : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Duelmen : Study site 2

Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)

View More »

Hamburg : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Mahlow : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Mainz : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Munich : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Munster : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Münster : Study Site 1

Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)

Paderborn : Study site 4

Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)

Tubingen : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Wiesbaden : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Wuppertal : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Hungary

Budapest : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Miskolc : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Szeged : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Szekszard : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Szolnok : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Israel

Tel-Aviv : Sourasky Medical Center

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients

Poland

Bialystok : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Gdansk : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Krakow : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Warszawa : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Wroclaw : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Romania

Brasov : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Bucharest : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Craiova : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Timisoara : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Tirgu Mures : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

United Kingdom

Berkshire : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Bexhill : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

London : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Nuneaton : Galderma Investigational Site

CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study